BioSig Technologies, Inc. STEX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$462.76M-4,376% | -$10.34M+63.9% | -$28.6M-5.7% | -$27.05M+15.2% | ||
| $3.53M+1,779% | $188K-47.9% | $361K+23.2% | $293K+48.0% | ||
| $57.1M+715% | $7.01M-13.8% | $8.13M+62.9% | $4.99M— | ||
| -$10.44M-119% | -$4.76M+72.5% | -$17.31M+20.2% | -$21.71M+17.8% | ||
| —— | —— | -$186K-10.7% | -$168K+69.0% | ||
| $45.36M— | —— | —— | —— | ||
| $8.05M— | —— | —— | —— | ||
| $54.88M+1,065% | $4.71M-72.8% | $17.33M+64.0% | $10.57M— | ||
| $21.08M+44,019% | -$48K— | —— | -$11.3M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioSig Technologies, Inc. generate?
- BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
- Where does BioSig Technologies, Inc.'s cash flow data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
